Sp1 Regulates the M1 Polarization of Microglia Through the HuR/NF-κB Axis after Spinal Cord Injury

Hangyu Guo1, Mingyu Du2, Yang Yang3

  • 1Department of Orthopedic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, PR China.

Neuroscience
|February 22, 2024
PubMed

Insights

Specificity protein 1 (Sp1) silencing restrains microglial M1 polarization and inflammation after spinal cord injury (SCI). This neuroprotective effect is mediated by inhibiting the HuR/NF-κB axis, promoting functional recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglial M1 polarization and pro-inflammatory mediator release impede functional recovery post-spinal cord injury (SCI).
  • Specificity protein 1 (Sp1) expression increases after SCI, but its role in microglial M1 polarization remains unclear.
  • RNA binding protein HuR is upregulated in injured spinal cords and implicated in neuroinflammation.

Purpose of the Study:

  • To investigate the function and regulatory mechanism of Sp1 in microglial M1 polarization following SCI.
  • To elucidate the relationship between Sp1 and HuR in the context of SCI-induced neuroinflammation.
  • To determine if targeting Sp1 can mitigate SCI-induced inflammation and promote recovery.

Main Methods:

  • Quantitative real-time PCR and Western blotting to assess Sp1 and HuR levels in SCI mice and LPS-treated BV2 cells.
  • In vitro assays to evaluate Sp1's role in microglial M1 polarization.
  • Gene transfection and luciferase reporter assays to confirm the Sp1-HuR association.

Main Results:

  • Sp1 knockdown suppressed M1 polarization and inflammation by inhibiting the NF-κB signaling pathway.
  • Silencing Sp1 reduced microglia activation and inflammatory response, effects reversed by HuR overexpression.
  • Enhanced HuR expression was observed in both SCI mice and LPS-treated BV2 cells.

Conclusions:

  • Silencing Sp1 restrains microglial M1 polarization via the HuR/NF-κB axis, offering neuroprotection.
  • Targeting Sp1 presents a potential therapeutic strategy for promoting functional restoration after SCI.
  • The Sp1-HuR interaction is a key mechanism in SCI-induced neuroinflammation.